Share Email Print

Proceedings Paper

Dye-enhanced diode laser photocoagulation of choroidal neovascularizations
Author(s): Ulrich Klingbeil; Carmen A. Puliafito M.D.; Dan McCarthy; Elias Reichel; Joseph Olk; Michael L. Lesiecki
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Dye-enhanced diode laser photocoagulation, using the dye indocyanine green (ICG), has shown some potential in the treatment of choroidal neovascularizations (CNV). A diode laser system was developed and optimized to emit at the absorption maximum of ICG. In a clinical study at two retinal centers, more than 70 patients, the majority of which had age-related macular degeneration, were treated. Eighteen cases with ill-defined subfoveal CNV were followed an average of 11 months after laser treatment. The results show success in resolving the CNV with an average long-term preservation of visual function equal to or superior to data provided by the Macular Photocoagulation Study for confluent burns of low intensity applied to the CNV. Details of the technique and discussion of the controversies inherent in such a treatment strategy will be presented.

Paper Details

Date Published: 23 June 1994
PDF: 9 pages
Proc. SPIE 2126, Ophthalmic Technologies IV, (23 June 1994); doi: 10.1117/12.178590
Show Author Affiliations
Ulrich Klingbeil, MetaSystems (United States)
Carmen A. Puliafito M.D., New England Eye Ctr./Tufts Univ. School of Medicine (United States)
Dan McCarthy, Oculon Corp. (United States)
Elias Reichel, New England Eye Ctr./Tufts Univ. School of Medicine (United States)
Joseph Olk, The Retina Consultants (United States)
Michael L. Lesiecki, Scion Scientific (United States)

Published in SPIE Proceedings Vol. 2126:
Ophthalmic Technologies IV
Jean-Marie A. Parel; Qiushi Ren, Editor(s)

© SPIE. Terms of Use
Back to Top